Celltex Therapeutics Corporation superheroes, 24-year-old Sarah Hughes and seven-year-old Tucker Beau Hyatt, were able to complete, for the first time ever, the annual Walk to Cure Arthritis on Saturday, May 16.
Diagnosed with systemic Juvenile Idiopathic Arthritis (JIA) at a young age, the duo attended last year’s 2014 Walk to Cure Arthritis, but were not physically able to walk with their teams. Both were pushed, in a wheelchair and stroller, respectively, for one-half mile but had to stop and go home, due to pain and weakness. Soon after, Sarah Hughes was admitted to the hospital.
Fast forward one year later, both Sarah and Tucker Beau attended the 2015 Walk to Cure Arthritis, arriving early to help with event set-up and even joined Master of Ceremonies, Mike Chabala, on stage. Most importantly, Sarah was able to walk the 1.5 mile route, and Tucker Beau ran the entire 5K on his own. After the event, both helped with post-event activities – a major turnaround from the year prior. Tucker Beau and Sarah proudly wore t-shirts that stated, “I am walking today because of my Celltex stem cells.”
Tucker Beau and Sarah were the first young people in the United States to receive a new therapy utilizing their own adult mesenchymal stem cells, made possible by Houston-based biotechnology company, Celltex Therapeutics Corporation. Sarah and Tucker Beau have been a source of inspiration for young people living with JIA and their families across the country, and both continue to see improvements in their daily quality of life following Celltex stem cell therapy.
“Celltex is proud to have served as the presenting sponsor of the 2015 Walk to Cure Arthritis,” Celltex Chairman and CEO David Eller says. “We are proud of Sarah and Tucker Beau. They have endured a lot in their youth and they really stand as a testament of bravery to us all. We’re pleased to see their quality of life has improved so much in just one year.”
The photos below demonstrate the difference one year can make.